Legal & General Group PLC Ikena Oncology, Inc. Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.5 - $7.31 $7,157 - $14,948	2,045 New	2,045 $13,000
Q2 2022 Aug 22, 2022	SELL	$3.23 - $7.4 $7,341 - $16,820	-2,273 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.52 - $16.96 $14,107 - $22,743	1,341 Added 143.88%	2,273 $29,000
Q3 2021 Nov 15, 2021	BUY	$9.82 - $15.23 $2,052 - $3,183	209 Added 28.91%	932 $12,000
Q2 2021 Aug 12, 2021	BUY	$13.27 - $26.0 $9,594 - $18,798	723 New	723 $10,000

33.2M

Ticker IKNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,257,500
Market Cap $52.2M
Description
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.